Cipla gets USFDA nod for pulmonary arterial hypertension drug

-
Cipla said the US sales of Letairis tablets USP stood at USD 943 million in 2018.

from Stocks-Markets-Economic Times http://bit.ly/2VBkyUm

Comments

Post a Comment

Popular posts from this blog

Gokaldas Exports reports 152% jump in revenues

-
Image
The company reported a profit before tax (PBT) of Rs 50.8 crore compared to a loss of Rs.2.6 crore in the same period last year and a PBT Rs 52.4 crore in the Jan-March quarter of the last fiscal year. In the first quarter of this fiscal year, the company considered a share-based compensation charge of Rs 6 crore, excluding which the profit before tax was Rs 56.8 crore. from Stocks-Markets-Economic Times https://ift.tt/biomg7W
Read more

Sebi mulls relaxation in timelines for FPIs' material change disclosures

-
In its consultation paper, Sebi proposed categorising material changes notified by FPIs into two groups to set timelines for reporting such changes. Type I includes changes that require FPIs to seek fresh registration, or which affect any privileges or exemption available to such foreign investors and Type II includes all other material changes. from Stocks-Markets-Economic Times https://ift.tt/aRgHPVe
Read more